Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 5 years by 15.76% on an annualized basis producing an average annual return of 29.94%. Currently, Regeneron Pharmaceuticals has a market capitalization of $115.55 billion.
Buying $100 In REGN: If an investor had bought $100 of REGN stock 5 years ago, it would be worth $373.39 today based on a price of $1048.18 for REGN at the time of writing.
Regeneron Pharmaceuticals's Performance Over Last 5 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
